TRU-1 by Blue Genes has officially launched, introducing a new approach to precision wellness through genetic insight. The platform is designed to help provide additional visibility into how individuals may respond differently to wellness strategies, supplements, and GLP-1 related programs based on their genetics.
Phoenix, AZ, January 16, 2026 — Blue Genes (https://bluegeneslab.com), a personalized medicine company focused on pharmacogenetic (PGx) testing and genetic insights to support safer, more effective medication decisions, today announced the successful completion of its SOC 2 Type II examination as of January 16, 2025.